Hsp90 inhibitors in parasitic nematodes: prospects and challenges

Article English OPEN
Devaney, Eileen ; Gillan, Victoria (2016)

Hsp90 inhibitors are well characterized in relation to their effects in a variety of tumors, with several inhibitors in various phases of clinical development. In recent years, the same inhibitor classes have been tested for efficacy in other systems, such as Alzheimer's disease and a variety of infectious disease models, including fungal and parasitic targets. In this article we discuss the repurposing of Hsp90 inhibitors for parasitic disease with a focus on parasitic nematode infections. We summarize the data that indicate that Hsp90 is functionally diverse in different nematode species and we discuss the challenges and prospects for developing these inhibitors as next generation chemotherapeutic tools.
  • References (60)
    60 references, page 1 of 6

    1. Taipale, M.; Jarosz, D. F.; Lindquist, S., HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nature reviews. Molecular cell biology 2010, 11 (7), 515-28.

    2. Echeverria, P. C.; Bernthaler, A.; Dupuis, P.; Mayer, B.; Picard, D., An interaction network predicted from public data as a discovery tool: application to the Hsp90 molecular chaperone machine. PloS one 2011, 6 (10), e26044.

    3. Neckers, L., Heat shock protein 90: the cancer chaperone. J Biosci 2007, 32 (3), 517-30.

    4. Burlison, J. A.; Avila, C.; Vielhauer, G.; Lubbers, D. J.; Holzbeierlein, J.; Blagg, B. S., Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines. The Journal of organic chemistry 2008, 73 (6), 2130-7.

    5. Taldone, T.; Ochiana, S. O.; Patel, P. D.; Chiosis, G., Selective targeting of the stress chaperome as a therapeutic strategy. Trends in pharmacological sciences 2014, 35 (11), 592-603.

    6. Neckers, L.; Trepel, J. B., Stressing the development of small molecules targeting HSP90. Clinical cancer research : an official journal of the American Association for Cancer Research 2014, 20 (2), 275-7.

    7. Pratt, W. B.; Gestwicki, J. E.; Osawa, Y.; Lieberman, A. P., Targeting hsp90/hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases. Annual review of pharmacology and toxicology 2015, 55, 353-71.

    8. Kamal, A.; Thao, L.; Sensintaffar, J.; Zhang, L.; Boehm, M. F.; Fritz, L. C.; Burrows, F. J., A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 2003, 425 (6956), 407-10.

    9. Moulick, K.; Ahn, J. H.; Zong, H.; Rodina, A.; Cerchietti, L.; Gomes DaGama, E. M.; Caldas-Lopes, E.; Beebe, K.; Perna, F.; Hatzi, K.; Vu, L. P.; Zhao, X.; Zatorska, D.; Taldone, T.; Smith-Jones, P.; Alpaugh, M.; Gross, S. S.; Pillarsetty, N.; Ku, T.; Lewis, J. S.; Larson, S. M.; Levine, R.; Erdjument-Bromage, H.; Guzman, M. L.; Nimer, S. D.; Melnick, A.; Neckers, L.; Chiosis, G., Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. Nature chemical biology 2011, 7 (11), 818-26.

    10. Devaney, E., Thermoregulation in the life cycle of nematodes. International journal for parasitology 2006, 36 (6), 641-9.

  • Related Research Results (2)
  • Metrics
    No metrics available
Share - Bookmark